These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Physiopathology and curative treatment of tardive dyskinesia]. Wolf MA; Gautier J Encephale; 1987; 13(5):301-8. PubMed ID: 2892663 [TBL] [Abstract][Full Text] [Related]
3. Evidence for an intrastriatal GABA control on motor activity arising from dopaminergic hyperfuction in the striatum. Scarnati E; Forchetti C; Ruggieri S; Agnoli A Acta Neurol (Napoli); 1978 Aug; 33(4):304-313. PubMed ID: 742442 [No Abstract] [Full Text] [Related]
4. [Implications of GABAergic synapses in neuropsychiatry]. Lloyd KG; Perrault G; Zivkovic B J Pharmacol; 1985; 16 Suppl 2():5-27. PubMed ID: 2867252 [TBL] [Abstract][Full Text] [Related]
7. New aspects on the role of dopamine, acetylcholine, and GABA in the development of tardive dyskinesia. Scheel-Krüger J; Arnt J Psychopharmacology Suppl; 1985; 2():46-57. PubMed ID: 2987907 [TBL] [Abstract][Full Text] [Related]
9. [Vacuous chewing after haloperidol and GABA-linoleamide administration in the rat]. Vamvakidès A Agressologie; 1986 Nov; 27(10):819-21. PubMed ID: 3812899 [No Abstract] [Full Text] [Related]
10. [What is the connection between Parkinson disease and tardive dyskinesia?]. Gunne LM; Andrén PE Lakartidningen; 1994 Aug; 91(34):2953-5. PubMed ID: 7990538 [No Abstract] [Full Text] [Related]
11. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid. Bishnoi M; Chopra K; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775 [TBL] [Abstract][Full Text] [Related]
12. GABA dysfunction in the pathophysiology of tardive dyskinesia. Tamminga CA; Thaker GK; Chase TN Psychopharmacology Suppl; 1985; 2():122-7. PubMed ID: 2987903 [TBL] [Abstract][Full Text] [Related]
14. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study. Rondot P; Bathien N Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446 [No Abstract] [Full Text] [Related]
15. Altered receptor sensitivity following chronic drug administration in man: the tardive dyskinesia model [proceedings]. Rubovits R Psychopharmacol Bull; 1977 Jan; 13(1):49-50. PubMed ID: 402011 [No Abstract] [Full Text] [Related]
16. [Role of monoamin- and GABA-ergic mechanisms of the caudate nucleus in the effects of reward and punishment]. Talalaenko AN Fiziol Zh SSSR Im I M Sechenova; 1987 Dec; 73(12):1630-2. PubMed ID: 2832218 [No Abstract] [Full Text] [Related]
17. U-93631 causes rapid decay of gamma-aminobutyric acid-induced chloride currents in recombinant rat gamma-aminobutyric acid type A receptors. Dillon GH; Im HK; Hamilton BJ; Carter DB; Gammill RB; Judge TM; Im WB Mol Pharmacol; 1993 Oct; 44(4):860-5. PubMed ID: 8232235 [TBL] [Abstract][Full Text] [Related]